BRR : 8528265
Tender Brief : Supply Of Inj. Tocilizumab 162 Mg / 0.9 Ml In Pfs (Brand - Actemra, Marketed By M/S Cipla Limited) Per Unitinj. Tocilizumab 162 Mg / 0.9 Ml In Pfs (Brand - Actemra, Marketed By M/S Cipla Limited) Per Unit,Inj. Tocilizumab 162 Mg / 0.9 Ml In Pfs (Brand - Actemra, Marketed By M/S Cipla Limit Ed) Per Unit (Item No. 2582 Of Si 2025-26) [Quantity Tolerance (+/-): 5 %Age , Item Category : Normal , Total Po Value Variation Permitted: Max 8 Lacs ] ] Read More
Tender Value
₹
Ref. Document
Contract Value
₹ 4,93,923.23
Submission Date
19-12-2025
Contract Date
01-01-2026
Completion Date
Ref. Document
Participated Bidder List
1 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | 4,93,923.23 | L1 |
Work Detail
supply of inj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limited) per unitinj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limited) per unit,inj. tocilizumab 162 mg / 0.9 ml in pfs (brand - actemra, marketed by m/s cipla limit ed) per unit (item no. 2582 of si 2025-26) [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
View Original Notice/Document
Result Documents
Tender Documents
| Download | File Name | File Description |
|---|---|---|
| Download | bb379758-df9d-4f4b-8995-cc5ff50a381c |
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
✦ ✦ ✦
Awarded Bidder(s)
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
Similar Tenders Results